Agomelatin for treatment of depressive disorders in Russia: a cost-utility analysis

Results Use of an agomelatin for treatment of a big depressive episode can be preferable alternative to use of fluoxetine and a sertralin as additional expenses for receiving 1 additional QALY make 341.9 and 637.0 [euro] respectively, that is significantly lower than the threshold value recommended...

Full description

Saved in:
Bibliographic Details
Published in:Clinical therapeutics 2015-08, Vol.37 (8), p.e102-e103
Main Authors: Ignatyeva, V.I, Frolov, M.Y, Avksentyeva, M.V
Format: Article
Language:English
Subjects:
Internal Medicine
Medical Education
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Results Use of an agomelatin for treatment of a big depressive episode can be preferable alternative to use of fluoxetine and a sertralin as additional expenses for receiving 1 additional QALY make 341.9 and 637.0 [euro] respectively, that is significantly lower than the threshold value recommended by WHO.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.294